October 6, 2009 - At the University of Virginia Health System where they opened a new Magnetic Resonance Guided Focused Ultrasound Surgery Center, specialists are using magnetic resonance guided focused ultrasound (MRgFUS) to perform research that will represent a wide range of disciplines, including anesthesiology, biomedical engineering, gynecology, neurology, neurosurgery, oncology, radiology, radiation oncology surgery and urology.

Within coming months, research will focus on using MRgFUS to treat brain, breast, prostate, bone and liver tumors and conditions such as epilepsy, stroke, chronic pain, Parkinson's disease and essential tremor.

Neal F. Kassell, M.D., a professor of neurosurgery at the University of Virginia's School of Medicine believes that MRgFUS may be the most important therapeutic development since the scalpel.

During MRgFUS treatments, which are noninvasive and performed on an outpatient basis, patients lie on a table while doctors use the visual capabilities of magnetic resonance imaging to direct hundreds of individual and normally harmless sound waves at a single treatment point deep inside the body.

When ultrasound waves intersect the intense energy destroys tumor cells, and according to Alan H. Matsumoto, M.D. and chairman of UVA’s Department of Radiology and co-director of the new center, the technology is so precise that it can treat sites as small as a millimeter.

Treatments, which will become available in late October, will take about three hours. Side effects, if any, are typically minimal - minor cramping is most common - and patients can expect to feel well enough to resume daily activities almost immediately.

James M. Larner, M.D., director of UVA's Focused Ultrasound Center and chairman of the Department of Radiation Oncology, notes that focused ultrasound has the ability to destroy 100 percent of cancer cells, unlike chemotherapy, which kills only a certain percentage of malignant cells. Also, cancer cells cannot become resistant to focused ultrasound in contrast to chemotherapy. In addition, focused ultrasound has a rapid dosing drop off, meaning the technology concentrates high levels of heat on a target site but does not spill over to nearby healthy tissue, potentially causing damage or patient complications.

For more information: www.virginia.edu


Related Content

News | Ultrasound Imaging

July 14, 2025 — Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant ...

Time July 14, 2025
arrow
News | Lung Imaging

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate ...

Time July 10, 2025
arrow
News | Breast Imaging

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...

Time July 09, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | FDA

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed ...

Time July 08, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Subscribe Now